Alimera Sciences, Inc. (ALIM) - Financial Analysis Review
18 Apr 2013
Available for Immediate Download
Alimera Sciences, Inc. (ALIM) - Financial Analysis Review Summary Alimera Sciences, Inc. (Alimera) is a biopharmaceutical company, based in the US. It offers research, development and commercialization of prescription ophthalmic pharmaceuticals. The company’s products are designed to treat early- and late-stage diseases such as diabetic macular edema (DME), wet and dry age-related macular degeneration (AMD) andretinal vein occlusion for retina specialists and their patients. Alimera’s products include ILUVIEN for DME and NADPH Oxidase Inhibitors. GlobalData's Alimera Sciences, Inc. (ALIM) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years. Alimera Sciences, Inc. Key Recent Developments: Mar 21, 2013: Alimera Sciences Reports 2012 Results Nov 07, 2012: Alimera Sciences Reports Q3 2012 Results Aug 09, 2012: Alimera Sciences Reports Q2 2012 Results May 11, 2012: Alimera Sciences Reports Q1 2012 Results Mar 08, 2012: Alimera Sciences Reports Q4 2011 Results This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description - A detailed description of the company's operations and business divisions. - Company history - Progression of key events associated with the company. - Major products and services - A list of major products, services and brands of the company. - Key competitors - A list of key competitors to the company. - Key employees - A list of the key executives of the company. - Executive biographies - A brief summary of the executives' employment history. - Key operational heads - A list of personnel heading key departments/functions. - Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details. - Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Note: Some sections may be missing if data is unavailable for the company. Reasons to Buy - Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. - Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services. - Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.